BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Deals

  Neos Therapeutics Announces Proposed Offering of Common Stock

  Neos Therapeutics, Inc. today announced that it has commenced an underwritten public offering of its common stock

  November 16, 2018

   · 

  4 min read
• Informa 2018 Survey predicts Drug Product Formulation Recognition and Budgets to increase significantly

  Formulation issues cause significant drug project delays and project failures, as experienced by 60% of survey participants.

  November 16, 2018

   · 

  8 min read
• Business

  Regenstrief, IU Public Health Name Dixon Director of Public Health Informatics

  Joint expertise to help tackle potential problems ranging from disease outbreaks to bioterrorism

  November 16, 2018

   · 

  4 min read
• Policy

  ACACIA PHARMA RESUBMITS BARHEMSYS™ NEW DRUG APPLICATION

  This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.

  November 16, 2018

   · 

  4 min read
• Business

  Secarna Pharmaceuticals and MetP Pharma enter into a co-development agreement for transnasally delivered antisense oligonucleotide-based CNS therapeutics

  Secarna’s proprietary antisense oligonucleotide platform LNAplusTM to be combined with MetP Pharma’s nasal drug delivery technology to develop novel treatment options for neurodegenerative diseases

  November 16, 2018

   · 

  4 min read
• Risk factors of type 2 diabetes and cardiovascular disease accumulate in children with poor aerobic fitness

  Risk factors of type 2 diabetes and cardiovascular disease accumulate in children who have poor aerobic fitness, a new study from the University of Eastern Finland shows.

  November 16, 2018

   · 

  2 min read
• iTeos Therapeutics to Present Data at 2018 SITC Annual Meeting

  iTeos Therapeutics SA today announced the presentation of two posters on its novel A2A receptor antagonist and TIGIT antibody programs, at the upcoming Society for Immunotherapy of Cancer (SITC) 33rd Annual Meeting, taking place from November 7-11, 2018 in Washington, D.C.

  November 16, 2018

   · 

  4 min read
• Business

  Optibrium and University of Nottingham Collaborate on Innovative Teaching Programme

  Provides students with the opportunity to design new drug-like molecules targeting fibrotic diseases and malaria with cutting-edge drug discovery software

  November 16, 2018

   · 

  5 min read
• BIO-Europe® Copenhagen’s Startup Slam Winner 2018: SunRegen Healthcare AG

  Winner SunRegen Healthcare is focused on innovative treatments for patients with neurodegenerative eye diseases

  November 16, 2018

   · 

  5 min read
• Biotech Beach

  MDxHealth (R): SelectMDx improves prostate biopsy decision-making in urology practices

  Real-world study shows that SelectMDx helps urologists more confidently determine the need for an initial prostate biopsy

  November 16, 2018

   · 

  6 min read